Bellevue Group’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $150M | Sell |
1,544,456
-3,461,263
| -69% | -$350M | 3.57% | 6 |
|
|
2025
Q4 | $399M | Sell |
5,005,719
-568,119
| -10% | -$37.3M | 7.56% | 1 |
|
|
2025
Q3 | $260M | Buy |
5,573,838
+994,538
| +22% | +$38.9M | 5.41% | 3 |
|
|
2025
Q2 | $168M | Buy |
4,579,300
+205,000
| +5% | +$7.88M | 3.71% | 10 |
|
|
2025
Q1 | $155M | Sell |
4,374,300
-12,600
| -0.3% | -$511K | 3.47% | 10 |
|
|
2024
Q4 | $192M | Sell |
4,386,900
-484,460
| -10% | -$24.4M | 3.69% | 7 |
|
|
2024
Q3 | $221M | Sell |
4,871,360
-157,740
| -3% | -$6.87M | 3.58% | 6 |
|
|
2024
Q2 | $195M | Sell |
5,029,100
-44,500
| -0.9% | -$1.66M | 3.17% | 8 |
|
|
2024
Q1 | $164M | Sell |
5,073,600
-17,400
| -0.3% | -$516K | 2.49% | 10 |
|
|
2023
Q4 | $146M | Buy |
5,091,000
+369,500
| +8% | +$8.88M | 2.23% | 11 |
|
|
2023
Q3 | $131M | Sell |
4,721,500
-24,500
| -0.5% | -$727K | 2.11% | 12 |
|
|
2023
Q2 | $127M | Sell |
4,746,000
-1,900
| -0% | -$46.6K | 1.81% | 14 |
|
|
2023
Q1 | $103M | Sell |
4,747,900
-107,262
| -2% | -$2.64M | 1.49% | 16 |
|
|
2022
Q4 | $116M | Buy |
4,855,162
+175,000
| +4% | +$3.72M | 1.53% | 17 |
|
|
2022
Q3 | $92.3M | Buy |
4,680,162
+1,296,900
| +38% | +$28.5M | 1.32% | 22 |
|
|
2022
Q2 | $65.9M | Buy |
3,383,262
+72,600
| +2% | +$1.41M | 0.93% | 37 |
|
|
2022
Q1 | $84.5M | Sell |
3,310,662
-159,500
| -5% | -$3.47M | 0.98% | 35 |
|
|
2021
Q4 | $87.3M | Buy |
3,470,162
+11,357
| +0.3% | +$320K | 0.9% | 36 |
|
|
2021
Q3 | $95.2M | Buy |
3,458,805
+1,604,000
| +86% | +$46.7M | 0.97% | 37 |
|
|
2021
Q2 | $58.9M | Buy |
1,854,805
+789,035
| +74% | +$27.5M | 0.57% | 60 |
|
|
2021
Q1 | $48.9M | Buy |
1,065,770
+1,025,770
| +2,564% | +$46M | 0.52% | 60 |
|
|
2020
Q4 | $1.58M | Buy |
+40,000
| New | +$1.58M | 0.02% | 147 |
|
Other funds holding RVMD
FCM
BBA
VCM
NI
VPM
PBA
